TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Multinational Study Of Efficacy And Safety Of Varenicline Tartrate For Smoking Cessation
Brief Summary: To investigate safety and efficacy of varenicline tartrate in helping people quit smoking


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: nicotine patch | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: nicotine lozenge | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: nicotine patch + nicotine lozenge | Arm Label: 4; Type: EXPERIMENTAL; Interventions: Drug: bupropion | Arm Label: 5; Type: EXPERIMENTAL; Interventions: Drug: bupropion + lozenge | Arm Label: 6; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: nicotine patch; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: nicotine lozenge; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: nicotine patch + nicotine lozenge; Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: bupropion; Assigned to Arm(s): 4 | Intervention Type: DRUG; Name: bupropion + lozenge; Assigned to Arm(s): 5 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 6
B: Arm Label: I; Type: EXPERIMENTAL; Interventions: Drug: bupropion SR, Behavioral: Cognitive Behavioral Group Therapy, Drug: nicotine replacement therapy | Arm Label: II; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Group Therapy, Drug: nicotine replacement therapy | Intervention Type: DRUG; Name: bupropion SR; Assigned to Arm(s): I | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Group Therapy; Assigned to Arm(s): I, II | Intervention Type: DRUG; Name: nicotine replacement therapy; Assigned to Arm(s): I, II
C: Arm Label: varenicline; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: support and visits, Drug: varenicline | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: support and visits, Drug: placebo | Intervention Type: BEHAVIORAL; Name: support and visits; Assigned to Arm(s): placebo, varenicline | Intervention Type: DRUG; Name: varenicline; Assigned to Arm(s): varenicline | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo
D: Intervention Type: DRUG; Name: Varenicline tartrate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Multinational Study Of Efficacy And Safety Of Varenicline Tartrate For Smoking Cessation
Brief Summary: To investigate safety and efficacy of varenicline tartrate in helping people quit smoking


Options:
A: Arm Label: Placebo (Slow Metabolizers); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Varenicline (Slow Metabolizers); Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline | Arm Label: Transdermal Nicotine (Slow Metabolizers); Type: ACTIVE_COMPARATOR; Interventions: Drug: Transdermal Nicotine | Arm Label: Placebo (Normal Metabolizers); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Varenicline (Normal Metabolizers); Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline | Arm Label: Transdermal Nicotine (Normal Metabolizers); Type: ACTIVE_COMPARATOR; Interventions: Drug: Transdermal Nicotine | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline (Normal Metabolizers), Varenicline (Slow Metabolizers) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo (Normal Metabolizers), Placebo (Slow Metabolizers) | Intervention Type: DRUG; Name: Transdermal Nicotine; Assigned to Arm(s): Transdermal Nicotine (Normal Metabolizers), Transdermal Nicotine (Slow Metabolizers)
B: Arm Label: Varenicline + Active Patch; Type: EXPERIMENTAL; Interventions: Drug: Nicotine Patch, Drug: Varenicline | Arm Label: Varenicline + Placebo Patch; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Varenicline | Intervention Type: DRUG; Name: Nicotine Patch; Assigned to Arm(s): Varenicline + Active Patch | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Varenicline + Placebo Patch | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline + Active Patch, Varenicline + Placebo Patch
C: Arm Label: varenicline; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: support and visits, Drug: varenicline | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: support and visits, Drug: placebo | Intervention Type: BEHAVIORAL; Name: support and visits; Assigned to Arm(s): placebo, varenicline | Intervention Type: DRUG; Name: varenicline; Assigned to Arm(s): varenicline | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo
D: Intervention Type: DRUG; Name: Varenicline tartrate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Multinational Study Of Efficacy And Safety Of Varenicline Tartrate For Smoking Cessation
Brief Summary: To investigate safety and efficacy of varenicline tartrate in helping people quit smoking


Options:
A: Arm Label: Control (Usual care); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Tobacco Cessation Tool (CATI Tool); Type: EXPERIMENTAL; Interventions: Behavioral: CATI Tool | Intervention Type: BEHAVIORAL; Name: CATI Tool; Assigned to Arm(s): Tobacco Cessation Tool (CATI Tool)
B: Arm Label: Combination zonisamide and bupropion with e-cigarette; Type: EXPERIMENTAL; Interventions: Drug: Bupropion, Drug: Zonisamide, Other: E-cigarette | Arm Label: Bupropion with e-cigarette; Type: EXPERIMENTAL; Interventions: Drug: Bupropion, Drug: Placebo zonisamide, Other: E-cigarette | Arm Label: Placebo with e-cigarette; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo bupropion, Drug: Placebo zonisamide, Other: E-cigarette | Intervention Type: DRUG; Name: Bupropion; Assigned to Arm(s): Bupropion with e-cigarette, Combination zonisamide and bupropion with e-cigarette | Intervention Type: DRUG; Name: Zonisamide; Assigned to Arm(s): Combination zonisamide and bupropion with e-cigarette | Intervention Type: DRUG; Name: Placebo bupropion; Assigned to Arm(s): Placebo with e-cigarette | Intervention Type: DRUG; Name: Placebo zonisamide; Assigned to Arm(s): Bupropion with e-cigarette, Placebo with e-cigarette | Intervention Type: OTHER; Name: E-cigarette; Assigned to Arm(s): Bupropion with e-cigarette, Combination zonisamide and bupropion with e-cigarette, Placebo with e-cigarette
C: Arm Label: Extended Varenicline Pretreatment; Type: EXPERIMENTAL; Interventions: Drug: Extended Varenicline Pretreatment | Arm Label: Short-term Varenicline Pretreatment; Type: EXPERIMENTAL; Interventions: Drug: Short-term Varenicline Pretreatment | Intervention Type: DRUG; Name: Extended Varenicline Pretreatment; Assigned to Arm(s): Extended Varenicline Pretreatment | Intervention Type: DRUG; Name: Short-term Varenicline Pretreatment; Assigned to Arm(s): Short-term Varenicline Pretreatment
D: Intervention Type: DRUG; Name: Varenicline tartrate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Multinational Study Of Efficacy And Safety Of Varenicline Tartrate For Smoking Cessation
Brief Summary: To investigate safety and efficacy of varenicline tartrate in helping people quit smoking


Options:
A: Arm Label: Scheduled Gradual Reduction + Varenicline; Type: EXPERIMENTAL; Interventions: Other: Scheduled Gradual Reduction + Varenicline | Arm Label: Scheduled Gradual Reduction + Placebo Drug; Type: EXPERIMENTAL; Interventions: Other: Scheduled Gradual Reduction + Placebo Drug | Arm Label: Basic Advice + Varenicline; Type: EXPERIMENTAL; Interventions: Other: Basic Advice + Varenicline | Arm Label: Basic Advice + Placebo Drug; Type: PLACEBO_COMPARATOR; Interventions: Other: Basic Advice + Placebo Drug | Intervention Type: OTHER; Name: Scheduled Gradual Reduction + Varenicline; Assigned to Arm(s): Scheduled Gradual Reduction + Varenicline | Intervention Type: OTHER; Name: Scheduled Gradual Reduction + Placebo Drug; Assigned to Arm(s): Scheduled Gradual Reduction + Placebo Drug | Intervention Type: OTHER; Name: Basic Advice + Varenicline; Assigned to Arm(s): Basic Advice + Varenicline | Intervention Type: OTHER; Name: Basic Advice + Placebo Drug; Assigned to Arm(s): Basic Advice + Placebo Drug
B: Arm Label: Varenicline pre-treatmemt; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Varenicline, Drug: Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Placebo, Varenicline pre-treatmemt | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Intervention Type: DRUG; Name: varenicline (CP-526,555); Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: Varenicline tartrate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Reducing Unsafe Drinking in HIV Primary Care
Brief Summary: The main aim of this study is to test an intervention to reduce unsafe drinking among HIV-positive primary care patients. The intervention consists of a brief motivational interview, which is combined with daily alcohol monitoring through the use of an interactive voice response system IVR (automated telephone system). Subjects who receive the enhanced motivational interview are expected to show greater improvements in drinking than individuals who receive the standard motivational interview or view a DVD on HIV self-care.


Options:
A: Arm Label: 1 - enhanced MI; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Motivational Interview | Arm Label: 2- standard MI; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Motivational Interview or viewing DVD | Intervention Type: BEHAVIORAL; Name: Enhanced Motivational Interview; Assigned to Arm(s): 1 - enhanced MI | Intervention Type: BEHAVIORAL; Name: Standard Motivational Interview or viewing DVD; Assigned to Arm(s): 2- standard MI
B: Arm Label: Usual Care; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: usual care | Arm Label: CHAT brief MI intervention; Type: EXPERIMENTAL; Interventions: Behavioral: CHAT brief MI intervention | Intervention Type: BEHAVIORAL; Name: CHAT brief MI intervention; Assigned to Arm(s): CHAT brief MI intervention | Intervention Type: BEHAVIORAL; Name: usual care; Assigned to Arm(s): Usual Care
C: Arm Label: Therapist-led brief intervention (TBI) - Cohort 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: TBI - Cohort 1 | Arm Label: Enhanced usual care - Cohort 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Therapist-led brief intervention (TBI) - Cohort 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: TBI - Cohort 2 | Arm Label: Enhanced usual care - Cohort 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: TBI - Cohort 1; Assigned to Arm(s): Therapist-led brief intervention (TBI) - Cohort 1 | Intervention Type: BEHAVIORAL; Name: TBI - Cohort 2; Assigned to Arm(s): Therapist-led brief intervention (TBI) - Cohort 2
D: Arm Label: C; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: MI; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): MI

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Reducing Unsafe Drinking in HIV Primary Care
Brief Summary: The main aim of this study is to test an intervention to reduce unsafe drinking among HIV-positive primary care patients. The intervention consists of a brief motivational interview, which is combined with daily alcohol monitoring through the use of an interactive voice response system IVR (automated telephone system). Subjects who receive the enhanced motivational interview are expected to show greater improvements in drinking than individuals who receive the standard motivational interview or view a DVD on HIV self-care.


Options:
A: Intervention Type: BEHAVIORAL; Name: Check Your Drinking (CYD); Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Alcohol Help Centre (AHC); Assigned to Arm(s): N/A
B: Arm Label: 1 - enhanced MI; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Motivational Interview | Arm Label: 2- standard MI; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Motivational Interview or viewing DVD | Intervention Type: BEHAVIORAL; Name: Enhanced Motivational Interview; Assigned to Arm(s): 1 - enhanced MI | Intervention Type: BEHAVIORAL; Name: Standard Motivational Interview or viewing DVD; Assigned to Arm(s): 2- standard MI
C: Arm Label: Monitoring Alone; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Monitoring plus contingency management for abstinence; Type: EXPERIMENTAL; Interventions: Behavioral: contingency management for abstinence | Intervention Type: BEHAVIORAL; Name: contingency management for abstinence; Assigned to Arm(s): Monitoring plus contingency management for abstinence
D: Arm Label: Promillekoll; Type: EXPERIMENTAL; Interventions: Behavioral: Promillekoll | Arm Label: PartyPlanner; Type: EXPERIMENTAL; Interventions: Behavioral: PartyPlanner | Arm Label: Control Study 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Crossover group 1: TeleCoach - Control; Type: EXPERIMENTAL; Interventions: Behavioral: TeleCoach | Arm Label: Crossover group 2: Control - TeleCoach; Type: EXPERIMENTAL; Interventions: Behavioral: TeleCoach | Intervention Type: BEHAVIORAL; Name: Promillekoll; Assigned to Arm(s): Promillekoll | Intervention Type: BEHAVIORAL; Name: PartyPlanner; Assigned to Arm(s): PartyPlanner | Intervention Type: BEHAVIORAL; Name: TeleCoach; Assigned to Arm(s): Crossover group 1: TeleCoach - Control, Crossover group 2: Control - TeleCoach

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Reducing Unsafe Drinking in HIV Primary Care
Brief Summary: The main aim of this study is to test an intervention to reduce unsafe drinking among HIV-positive primary care patients. The intervention consists of a brief motivational interview, which is combined with daily alcohol monitoring through the use of an interactive voice response system IVR (automated telephone system). Subjects who receive the enhanced motivational interview are expected to show greater improvements in drinking than individuals who receive the standard motivational interview or view a DVD on HIV self-care.


Options:
A: Arm Label: 1 - enhanced MI; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Motivational Interview | Arm Label: 2- standard MI; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Motivational Interview or viewing DVD | Intervention Type: BEHAVIORAL; Name: Enhanced Motivational Interview; Assigned to Arm(s): 1 - enhanced MI | Intervention Type: BEHAVIORAL; Name: Standard Motivational Interview or viewing DVD; Assigned to Arm(s): 2- standard MI
B: Arm Label: ATSM Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ATSM Intervention | Arm Label: GMV Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: GMV Intervention | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ATSM Intervention; Assigned to Arm(s): ATSM Intervention | Intervention Type: BEHAVIORAL; Name: GMV Intervention; Assigned to Arm(s): GMV Intervention
C: Arm Label: UC; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: TM; Type: EXPERIMENTAL; Interventions: Other: Telemonitoring | Intervention Type: OTHER; Name: Telemonitoring; Assigned to Arm(s): TM
D: Arm Label: Technology-supported care; Type: EXPERIMENTAL; Interventions: Other: Technology-supported care | Arm Label: Supported-Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Technology-supported care; Assigned to Arm(s): Technology-supported care

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective and Comparative Study of the Performance of Tension Free Vaginal Mesh (Prolift) Versus Conventional Vaginal Prolapse Surgery in Recurrent Prolapse
Brief Summary: Pelvic organ prolapse is a common problem. A lot of women have surgery for prolapse. The recurrence rate op pelvic organ prolapse after surgical treatment is high. Placement of a mesh aims at reducing the recurrence rate, but mesh implants can cause complications.

This study is designed to determine the effectiveness of one type of mesh (tensionfree vaginal mesh; Prolift), compared with the standard prolapse surgery. A secondary objective is to track the complications of both procedures.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Anterior colporrhaphy | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Anterior PROLIFT | Intervention Type: PROCEDURE; Name: Anterior colporrhaphy; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Anterior PROLIFT; Assigned to Arm(s): 2
B: Arm Label: Mesh surgery; Type: EXPERIMENTAL; Interventions: Device: Tensionfree vaginal mesh kit (Prolift) | Arm Label: Conventional vaginal surgery; Type: ACTIVE_COMPARATOR; Interventions: Procedure: classic vaginal prolapse surgery (fascia plication) | Intervention Type: DEVICE; Name: Tensionfree vaginal mesh kit (Prolift); Assigned to Arm(s): Mesh surgery | Intervention Type: PROCEDURE; Name: classic vaginal prolapse surgery (fascia plication); Assigned to Arm(s): Conventional vaginal surgery
C: Arm Label: Anterior Colporrhaphy (sutured repair); Type: PLACEBO_COMPARATOR; Interventions: Procedure: sutured anterior vaginal prolapse repair | Arm Label: Perigee (grafted repair); Type: ACTIVE_COMPARATOR; Interventions: Device: grafted anterior prolapse repair | Intervention Type: DEVICE; Name: grafted anterior prolapse repair; Assigned to Arm(s): Perigee (grafted repair) | Intervention Type: PROCEDURE; Name: sutured anterior vaginal prolapse repair; Assigned to Arm(s): Anterior Colporrhaphy (sutured repair)
D: N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective and Comparative Study of the Performance of Tension Free Vaginal Mesh (Prolift) Versus Conventional Vaginal Prolapse Surgery in Recurrent Prolapse
Brief Summary: Pelvic organ prolapse is a common problem. A lot of women have surgery for prolapse. The recurrence rate op pelvic organ prolapse after surgical treatment is high. Placement of a mesh aims at reducing the recurrence rate, but mesh implants can cause complications.

This study is designed to determine the effectiveness of one type of mesh (tensionfree vaginal mesh; Prolift), compared with the standard prolapse surgery. A secondary objective is to track the complications of both procedures.


Options:
A: Arm Label: Intervention: Collagen matrix; Type: EXPERIMENTAL; Interventions: Procedure: Collagen Matrix | Arm Label: Native tissue repair; Type: OTHER; Interventions: Procedure: Collagen Matrix | Intervention Type: PROCEDURE; Name: Collagen Matrix; Assigned to Arm(s): Intervention: Collagen matrix, Native tissue repair
B: Arm Label: Mesh surgery; Type: EXPERIMENTAL; Interventions: Device: Tensionfree vaginal mesh kit (Prolift) | Arm Label: Conventional vaginal surgery; Type: ACTIVE_COMPARATOR; Interventions: Procedure: classic vaginal prolapse surgery (fascia plication) | Intervention Type: DEVICE; Name: Tensionfree vaginal mesh kit (Prolift); Assigned to Arm(s): Mesh surgery | Intervention Type: PROCEDURE; Name: classic vaginal prolapse surgery (fascia plication); Assigned to Arm(s): Conventional vaginal surgery
C: Arm Label: Polypropylene Mesh; Type: ACTIVE_COMPARATOR; Interventions: Device: Polypropylene mesh (Polyform by Boston Scientific) | Arm Label: Anterior Colporrhaphy; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Anterior Colporrhaphy | Arm Label: Porcine Dermis; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Porcine Dermis (Pelvicol by CRBard) | Intervention Type: DEVICE; Name: Polypropylene mesh (Polyform by Boston Scientific); Assigned to Arm(s): Polypropylene Mesh | Intervention Type: PROCEDURE; Name: Porcine Dermis (Pelvicol by CRBard); Assigned to Arm(s): Porcine Dermis | Intervention Type: PROCEDURE; Name: Anterior Colporrhaphy; Assigned to Arm(s): Anterior Colporrhaphy
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Control | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Graft augmented posterior repair | Intervention Type: PROCEDURE; Name: Graft augmented posterior repair; Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: Control; Assigned to Arm(s): 1

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective and Comparative Study of the Performance of Tension Free Vaginal Mesh (Prolift) Versus Conventional Vaginal Prolapse Surgery in Recurrent Prolapse
Brief Summary: Pelvic organ prolapse is a common problem. A lot of women have surgery for prolapse. The recurrence rate op pelvic organ prolapse after surgical treatment is high. Placement of a mesh aims at reducing the recurrence rate, but mesh implants can cause complications.

This study is designed to determine the effectiveness of one type of mesh (tensionfree vaginal mesh; Prolift), compared with the standard prolapse surgery. A secondary objective is to track the complications of both procedures.


Options:
A: Arm Label: Mesh surgery; Type: EXPERIMENTAL; Interventions: Device: Tensionfree vaginal mesh kit (Prolift) | Arm Label: Conventional vaginal surgery; Type: ACTIVE_COMPARATOR; Interventions: Procedure: classic vaginal prolapse surgery (fascia plication) | Intervention Type: DEVICE; Name: Tensionfree vaginal mesh kit (Prolift); Assigned to Arm(s): Mesh surgery | Intervention Type: PROCEDURE; Name: classic vaginal prolapse surgery (fascia plication); Assigned to Arm(s): Conventional vaginal surgery
B: Arm Label: Anterior colporrhaphy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: anterior vaginal repair (colporrhaphy), Procedure: abdominal paravaginal defect repair | Arm Label: Paravaginal defect repair; Type: ACTIVE_COMPARATOR; Interventions: Procedure: anterior vaginal repair (colporrhaphy), Procedure: abdominal paravaginal defect repair | Intervention Type: PROCEDURE; Name: anterior vaginal repair (colporrhaphy); Assigned to Arm(s): Anterior colporrhaphy, Paravaginal defect repair | Intervention Type: PROCEDURE; Name: abdominal paravaginal defect repair; Assigned to Arm(s): Anterior colporrhaphy, Paravaginal defect repair
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Anterior colporrhaphy | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Anterior PROLIFT | Intervention Type: PROCEDURE; Name: Anterior colporrhaphy; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Anterior PROLIFT; Assigned to Arm(s): 2
D: Arm Label: Prolift mesh; Type: ACTIVE_COMPARATOR; Interventions: Device: synthetic monofilament polypropylene mesh | Arm Label: Prolapse repair without mesh; Type: ACTIVE_COMPARATOR; Interventions: Device: synthetic monofilament polypropylene mesh | Intervention Type: DEVICE; Name: synthetic monofilament polypropylene mesh; Assigned to Arm(s): Prolapse repair without mesh, Prolift mesh

Answer: A